Haemonetics Q2 Adj. EPS $1.35 Beats $1.29 Estimate, Sales $357.759M Beat $345.003M Estimate
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Beats
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.29 by 4.65 percent. This is a 6.3 percent increase over earnings of $1.27 per share from the same
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.29 by 4.65 percent. This is a 6.3 percent increase over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $357.759 million which beat the analyst consensus estimate of $345.003 million by 3.70 percent. This is a 9.30 percent increase over sales of $327.316 million the same period last year.